content

1st-line Tagrisso demonstrates sustained benefit post progression in patients with EGFR-mutated non-small cell lung cancer

AstraZeneca presented new post-progression outcomes data from an exploratory analysis of the global Phase III FLAURA trial, which assessed the efficacy and safety of...

Nordic Nanovector Presents Preclinical Data at AACR 2018

Nordic Nanovector ASA announces that a poster reporting the anti-tumour effect of Humalutinยฎ (177Lu-conjugated humanized anti-CD37 antibody, 177Lu-NNV003) in preclinical models of non-Hodgkin's lymphoma...

Apitope Announces Positive Results with Novel Treatment for Graves’ Disease

Apitope, a clinical stage biotech company developing potential first-in-class antigen-specific immunotherapies targeting autoimmune diseases (including multiple sclerosis (MS), Graves' disease and uveitis), announced positive...

Novartis announces new analysis demonstrating Entresto helped preserve kidney function in patients with chronic heart failure, especially those with diabetes

Novartis announced a new post hoc analysis of the pivotal Phase III heart failure study, PARADIGM-HF, demonstrating that treatment with Entrestoยฎ (sacubitril/valsartan) helped to...

Oncology Company Hercules Pharmaceuticals to Present AhR Inhibitor Efficacy Results at Upcoming AACR Meeting on Monday April 16

Hercules Pharmaceuticals, a Dutch biopharmaceutical company developing innovative anti-cancer drugs will present a poster, Poster LB-128, at the AACR meeting in Chicago on Monday...

MIMETAS Secures 20 Million Dollar Series B Financing

MIMETAS, leader in organ-on-a-chip products and tissue models, has secured 20.5 million USD in financing from an international syndicate from Asia and Europe. ...

TraceLink Unveils EU FMD Express, a Purpose-Built Compliance Solution for Smaller Pharmaceutical Companies

TraceLink Inc., the Worldโ€™s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read